(NaturalNews) The Food and Drug Administration (FDA) on Aug. 6 licensed Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults 50 and older â marking the first …
Report: FDA’s Review of Moderna’s mRNA Flu Vaccine Concealed Statistically Significant Safety Signal
Estimated read time
1 min read
